Coronary artery surgery: The end of the beginning

European Journal of Cardio-thoracic Surgery

Volumn 14, Issue 6, 1998, Pages 554-571

  Loop, Floyd D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Angioplasty; Coronary artery surgery; Internal thoracic artery grafts; Minimal access; Robotic; Vein graft atherosclerosis

Indexed keywords

ABCIXIMAB; ANTILIPEMIC AGENT; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; COLESTYRAMINE; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; VASCULOTROPIN;

ATHEROSCLEROSIS; CLINICAL TRIAL; CORONARY ARTERY SURGERY; DIABETES MELLITUS; GASTROEPIPLOIC ARTERY; GRAFT FAILURE; HEART MUSCLE REVASCULARIZATION; HUMAN; OPERATING ROOM; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RADIAL ARTERY; REOPERATION; RESTENOSIS; REVIEW; ROBOTICS; SAPHENOUS VEIN GRAFT; STENT; SURGICAL INSTRUMENT; THROMBOSIS;

CORONARY ARTERIOSCLEROSIS; GRAFT OCCLUSION, VASCULAR; HUMANS; MYOCARDIAL REVASCULARIZATION; PATIENT SELECTION; RADIOLOGY, INTERVENTIONAL; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 0032443636     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(98)00249-8     Document Type: Review

References (132)

1. [1] Bohr N. In: Mackay AL, ed. A dictionary of scientific quotations. Philadelphia: A. Hilger, 1991:35.
2. [2] Steinberg D. Oxidative modification of LDL and atherogenesis. Circulation 1997;95:1062-1071.
3. [3] Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995; 91:2488-2496.
4. [4] Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-671.
5. [5] Farb A, Burke AP, Tang AL, Liang Y, Mannan P, Smialek J, Virmani R. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996;93:1354-1363.
6. [6] Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR, Santamore WP. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?. Circulation 1988;78:1157-1166.
7. [7] Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371-1375.
8. [8] Randomised trial of cholesterol-lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
9. [9] Vos J, de Feyter PJ, Simoons ML, Tijssen JG, Deckers JW. Retardation and arrest of progression or regression of coronary artery disease: a review. Prog Cardiovasc Dis 1993;35:435-454.
10. [10] Superko HR, Krauss RM. Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management. Circulation 1994;90:1056-1069.
11. [11] Lewis SJ, Sacks FM, Mitchell JS, East C, Glasser S, Kell S, Letterer R, Limacher M, Moye LA, Rouleau JL, Pfeffer MA, Braunwald E for the CARE investigators. Effect of pravastatin on cardiovascular events in women after myocardial infarction: the Cholesterol and Recurrent Events (CARE) Trial. J Am Coll Cardiol 1998;32:140-146.
12. [12] Miller ER 3rd, Appel LJ, Jiang L, Rispy TH. Association between cigarette smoking and lipid peroxidation in a controlled feeding study. Circulation 1997;96:1097-1101.
13. [13] Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993;167:841-849.
14. [14] Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996;27:517-527.
15. 165 in patient with ischaemic limb. Lancet 1996;348:370-374.
16. [16] Rimm AA, Bortin M. Trialism: clinical trials as a religion. Biomedicine 1978;28:60-63.
17. [17] Ingelfinger FJ. Arrogance. N Engl Med 1993;303:1507-1511.
18. [18] European Coronary Surgery Study Group Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982;2:1173-1180.
19. [19] Takaro T, Hultgren HN, Lipton MJ, Detre KM. The VA Cooperative randomized study of surgery for coronary arterial occlusive disease II: subgroup with significant left main lesions. Circulation 1976;54 (Suppl III ):III107-III117.
20. [20] Coronary Artery Surgery Study (CASS) A randomized trial of coronary artery bypass surgery: survival data. Circulation 1983;68:939-950.
21. [21] Loop FD. CASS continued. Circulation 1985;72 (Suppl II ):II1-II6.
22. [22] Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, Levine F, Schloss M. Results of coronary artery surgery in patients with poor left ventricular function (C.A.SS). Circulation 1983;68:785-795.
23. [23] Myers WO, Schaff HV, Gersh BJ, Fisher LD, Kosinski AS, Mock MB, Holmes DR, Ryan TJ, Kaiser GC. Improved survival of surgically treated patients with triple vessel coronary artery disease and severe angina pectoris. A report from the Coronary Artery Surgery Study (CASS) registry. J Thorac Cardiovasc Surg 1989;97:487-495.
24. [24] Myers WO, Gersh BJ, Fisher LD, Mock MB, Schaff HV, Gillispie S, Ryan TJ, Kaiser GC. Medical versus early surgical therapy in patients with triple-vessel disease and mild angina pectoris: a CASS registry study of survival. Ann Thorac Surg 1987;44:471-486.
25. [25] Gersh BJ, Kronmal RA, Schaff HV, Frye RL, Ryan TJ, Myers WO, Athearn MW, Gosselin AJ, Kaiser GC, Killip T. III. Long-term (5 year) results of coronary bypass surgery in patients 65 years old or older: a report from the Coronary Artery Bypass Surgery Study. Circulation 1983;68 (Suppl II ):II190-II199.
26. [26] Myers WO, Schaff HV, Fisher LD, Gersh BJ, Mock MB, Holmes DR, Gillispie S, Ryan TJ, Kaiser GC. Time to first new myocardial infarction in patients with severe angina and three-vessel disease comparing medical and early surgical therapy: a CASS registry study of survival. J Thorac Cardiovasc Surg 1988;95:382-389.
27. [27] Alderman EL, Bourassa MG, Cohen LS, Davis KB, Kaiser GG, Killip T, Mock MB, Pettinger M, Robertson TL. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation 1990;82:1629-1646.
28. [28] Rowe GG. Coronary artery bypass surgery (letter). Lancet 1978;1:264-265.
29. [29] Proudfit WL, Bruschke AV, Sones FM Jr. Natural history of obstructive coronary artery disease: ten-year study of 601 nonsurgical cases. Prog Cardiovasc Dis 1978;21:53-78.
30. [30] Loop FD, Cosgrove DM, Lytle BW, Thurer RL, Simpfendorfer C, Taylor PC, Proudfit WL. An 11 year evolution of coronary arterial surgery (1967-1978). Ann Surg 1979;190:444-455.
31. [31] Rosati R, McNeer JF, Starmer C, Mittler BS, Morris JJ Jr, Wallace AG. A new information system for medical practice. Arch Intern Med 1975;135:1017-1024.
32. [32] Loop FD, Berrettoni JN, Pichard A, Siegel W, Razavi M, Effler DB. Selection of the candidate for myocardial revascularization: a profile of high risk based on multivariate analysis. J Thorac Cardiovasc Surg 1975;69:40-51.
33. [33] Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. J Am Med Assoc 1992;267:2344-2348.
34. [34] Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 1989;79 (Suppl I ):I3-I12.
35. [35] Hannan EL, Kilburn H, O'Donnell JF, Lukacik G, Shields EP. Adult open heart surgery in New York State. An analysis of risk factors and hospital mortality rates. J Am Med Assoc 1990;264:2768-2774.
36. [36] Barnes E, Dutka D, Hall RJ, Camici PG. The viable myocardium. Lancet 1998;351:1816-1817.
37. [37] Wijns W, Vatner SF, Camici PG. Hibernating myocardium (review). N Engl J Med 1998;339:173-181.
38. [38] Bourassa MG, Lesperance J, Corbara F, Saltiel J, Campeau L. Progression of obstructive coronary artery disease 5 to 7 years after aortocoronary bypass surgery. Circulation 1978;58 (Suppl. I ):I100-I106.
39. [39] Campeau L, Crochet D, Lesperance J, Bourassa MG, Grondin CM. Postoperative changes in aortocoronary saphenous vein grafts revisited: angiographic studies at two weeks and one year in two series of consecutive patients. Circulation 1975;52:369-377.
40. [40] Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easley K, Taylor PC. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg 1985;89:248-258.
41. [41] Campeau L, Enjalbert M, Lesperance J, Vaislic C, Grondin CM, Bourassa MG. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery. Circulation 1983;68 (Suppl II ):II1-II7.
42. [42] Nwasokwa ON. Coronary artery bypass graft disease. Ann Intern Med 1995;123:528-545.
43. [43] Loop FD, Irarrazaval M, Bredee J, Siegel W, Taylor PC, Sheldon WC. Internal mammary artery graft for ischemic heart disease. Effect of revascularization on clinical status and survival. Am J Cardiol 1977;39:516-522.
44. [44] Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, Golding LA, Gill CC, Taylor PC, Sheldon WC, Proudfit WL. Influence of the internal mammary artery graft on 10-year survival and other cardiac events. N Engl J Med 1986;314:1-6.
45. [45] Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with internal-thoracic-artery grafts: effects on survival over a 15-year period. N Engl J Med 1996;334:216-219.
46. [46] Chesebro JH, Clements IP, Fuster V, Elveback LR, Smith HC, Bardsley WT, Frye RL, Holmes DR Jr, Vlietstra RE, Pluth JR, Wallace RB, Puga FJ, Orszulak TA, Piehler JM, Schaff HV, Danielson GK. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med 1982;307:73-78.
47. [47] Topol EJ. Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence. Circulation 1998;97:211-218.
48. [48] Fisher LD, Kennedy JW, Davis KB, Maynard C, Fritz JK, Kaiser G, Myers WO. Association of sex, physical size, and operative mortality after coronary artery bypass in the Coronary Artery Surgery Study (CASS). J Thorac Cardiovasc Surg 1982;84:334-341.
49. [49] Loop FD, Golding LR, MacMillan JP, Cosgrove DM, Lytle BW, Sheldon WC. Coronary artery surgery in women compared with men: analyses of risks and long-term results. J Am Coll Cardiol 1983;1:383-390.
50. [50] O'Connor GT, Morton JR, Diehl MJ, Olmstead EM, Coffin LH, Levy DG, Maloney CT, Plume SK, Nugent W, Malenka DJ. for the Northern New England Cardiovascular Disease Study Group. Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. Circulation 1993;88(I):2104-2110.
51. [51] Edwards FH, Carey JS, Grover FL, Bero JW, Hartz RS. Impact of gender on coronary bypass operative mortality. Ann Thorac Surg 1998;66:125-131.
52. [52] Davis KB, Chaitman B, Ryan T, Bittner V, Kennedy JW. Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study. Coronary Artery Surgery Study. J Am Coll Cardiol 1995;25:1000-1009.
53. [53] Lazar HL, Menzoian JO. Coronary artery bypass grafting in patients with cerebroavascular disease. Ann Thorac Surg 1998;66:868-947.
54. [54] Loop FD. Coronary artery bypass surgery. In: Topol EJ, ed. Textbook of Cardiovascular Medicine. Philadelphia: Lippincott-Raven, 1998:2011-2031.
55. [55] Noyez L, Janssen DP, van Druten JA, Skotnicki SH, Lacquet LK. Coronary bypass surgery: what is changing? Analysis of 3834 patients undergoing primary isolated myocardial revascularization. Eur J Cardio-thorac Surg 1998;13:365-369.
56. [56] Bourassa MG. The natural history of saphenous vein bypass graft disease. In: Bates ER, Holmes DR Jr, eds. Saphenous vein bypass graft disease. New York: Marcel Dekker, 1998;61-76.
57. [57] Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998;97: 916-931.
58. [58] FitzGibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996;28:616-626.
59. [59] Solymoss BC, Nadeau P, Millette D, Campeau L. Late thrombosis of saphenous vein coronary bypass grafts related to risk factors. Circulation 1988;78 (Suppl I ):I140-I143.
60. [60] Lytle BW, Loop FD, Taylor PC, Simpfendorfer C, Kramer JR, Ratliff NB, Goormastic M, Cosgrove DM. Vein graft disease: the clinical impact of stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg 1992;103:831-840.
61. [61] Blankenhorn DN, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. J Am Med Assoc 1987;257:3233-3240.
62. [62] The Post-Coronary Artery Bypass Graft Trial Investigators The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary artery bypass grafts. N Engl J Med 1997;336:153-162.
63. [63] Reardon MJ, Conklin LD, Reardon PR, Baldwin JC. Coronary artery bypass conduits: review of current status. J Cardiovasc Surg 1997;38:201-209.
64. [64] Luscher TF, Diederich D, Siebenmann R, Lehmann K, Stulz P, von Segesser L, Yang ZH, Turina M, Gradel E, Weber E, Buhler FR. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med 1988;319: 462-467.
65. [65] Pearson PJ, Evora PR, Schaff HV. Bioassay of EDRF from internal mammary arteries: implications for early and late bypass graft patency. Ann Thorac Surg 1992;54:1078-1084.
66. [66] Edwards FH, Clark RE, Schwartz M. Impact of internal mammary artery conduits on operative mortality in coronary revascularization. Ann Thorac Surg 1994;57:27-32.
67. [67] Grover FL, Johnson RR, Marshall G, Hammermeister KE. Impact of mammary grafts on coronary bypass operative mortality and morbidity. Department of Veterans Affairs Cardiac Surgeons. Ann Thorac Surg 1994;57:559-568.
68. [68] Loop FD, Thomas JD. Hypoperfusion after arterial bypass grafting (editorial). Ann Thorac Surg 1993;56:812-813.
69. [69] Gaudino M, Trani C, Luciani N, Alessandrini F, Possati G. The internal mammary artery malperfusion syndrome: late angiographic verification. Ann Thorac Surg 1997;63:1257-1261.
70. [70] Loop FD, Lytle BW, Cosgrove DM, Golding LAR, Taylor PC, Stewart RW. Free (aorta-coronary) internal mammary artery graft. J Thorac Cardiovasc Surg 1986;92:827-831.
71. [71] Loop FD. Internal-thoracic-artery grafts: biologically better coronary arteries. N Engl J Med 1996;334:263-265.
72. [72] Leavitt BJ, Olmstead EM, Plume SK, Charlesworth DC, Maislen EL, James TW, Baribeau YR, Quinn R, O'Connor GT. Use of the internal mammary artery graft in Northern New England. New England Cardiovascular Disease Study Group. Circulation 1997; 96 (Suppl II):II32-II37.
73. [73] Tobler HG, Sethi GK, Grover FL, Shroyer AL, Moritz TE, Henderson WG, Hammermeister KE. Variation in processes and structures of cardiac surgery practice. Med Care 1995;33:OS43-OS58.
74. [74] Hannan EL. New York State Department of Health, pers. commun.
75. [75] Society of Thoracic Surgeons National Cardiac Database. Summit Medical Systems, Inc.
76. [76] Sergeant P, Blackstone E, Meyns B. Is return of angina after coronary artery bypass grafting immutable, can it be delayed, is it important?. J Thorac Cardiovasc Surg 1998;116:440-453.
77. [77] Sergeant P, Blackstone E, Meyns B. Does arterial revascularization decrease the risk of infarction after coronary artery bypass grafting?. Ann Thorac Surg 1998;66:1-11.
78. [78] Lytle BW, Arnold JH, Loop FD, Akhrass RMK, Houghtaling PL, Blackstone EH, McCarthy PM, Cosgrove DM. Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc Surg 1998; in press.
79. [79] Morris JJ, Smith LR, Jones RH, Glower DD, Morris PB, Muhlbaier LH, Reeves JG, Rankin JS. Influence of diabetes and mammary artery grafting on survival after coronary bypass. Circulation 1991;84 (Suppl III ):III275-III84.
80. [80] Sergent P, Blackstone E, Meyns B et al. Freedom from first cardiological or cardiosurgical reintervention for ischemic heart disease after primary CABG. Eur J Cardio-thorac Surg, 1998; in press.
81. [81] Pick AW, Orszulak TA, Anderson BJ, Schaff HV. Single versus bilateral internal mammary artery grafts: 10-year outcome analysis. Ann Thorac Surg 1997;64:599-605.
82. [82] Loop FD, Lytle BW, Cosgrove DM, Mahfood S, McHenry MC, Goormastic M, Stewart RW, Golding LAR, Taylor PC. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. J. Maxwell Chamberlain Memorial Paper. Ann Thorac Surg 1990; 49:179-187.
83. [83] Bitkover CY, Gardlund B. Mediastinitis after cardiovascular operations: a case-control study of risk factors. Ann Thorac Surg 1998;65:36-40.
84. [84] Matsumoto M, Konishi Y, Miwa S, Minakata K. Effect of different methods of internal thoracic artery harvest on pulmonary function. Ann Thorac Surg 1997;63:653-655.
85. [85] Furnary AP, Zerr KJ, Grunkemeier GL et al. Continuous intravenous insulin infusion reduces risk of deep sternal wound infection in diabetic cardiac surgery patients. Ann of Thorac Surg 1998; in press.
86. [86] Carrier M, Gregoire J, Tronc F, Cartier R, Leclerc Y, Pelletier LC. 1992: effect of internal mammary artery dissection on sternal vascularization. 1993 update. Ann Thorac Surg 1993;55:803-804.
87. [87] Cruse PJE, Foord R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980;60:27-40.
88. [88] Thiele RI, Jakob HG, Borneff M, Bach A, Puckler S, Windeler J, Sonntag HG, Hagl S. The endogenous pathway is a major route for deep sternal wound infection. J Thorac Cardiovasc Surg 1998; in press.
89. [89] Acar C, Jebara VA, Portoghese M, Beyssen B, Pagny JY, Grare P, Chachques JC, Fabiani JN, Deloche A, Guermonprez JL. Revival of the radial artery for coronary artery bypass grafting. Ann Thorac Surg 1992;54:652-659.
90. [90] Brodman RF, Frame R, Camacho M, Hu E, Chen A, Hollinger I. Routine use of unilateral and bilateral radial arteries for coronary artery bypass graft surgery. J Am Coll Cardiol 1996;28:959-963.
91. [91] Calafiore AM, Di Giammarco G, Teodori G, D'Annunzio E, Vitolla G, Fino C, Maddestra N. Radial artery and inferior epigastric artery in composite grafts: improved midterm angiographic results. Ann Thorac Surg 1995;60:517-523.
92. [92] Manasse E, Sperti G, Suma H, Canosa C, Kol A, Martinelli L, Schiavello R, Crea F, Maseri A, Possati GF. Use of the radial artery for myocardial revascularization. Ann Thorac Surg 1996;62:1076-1082.
93. [93] Angelini GD, Bryan AJ, Dion R. Arterial Conduits in Myocardial Revascularization. London: Arnold, 1996.
94. [94] van Son JA, Smedts F, Vincent JG, van Lier HJ, Kubat K. Comparative anatomic studies of various arterial conduits for myocardial revascularization. J Thorac Cardiovasc Surg 1990;99:703-707.
95. [95] Shapira OM, Alkon JD, Aldea GS, Madera F, Lazar HL, Shemin RJ. Clinical outcomes in patients undergoing coronary artery bypass grafting with preferred use of the radial artery. J Card Surg 1997;12:381-388.
96. [96] He GW. Verapamil plus nitroglycerin solution maximally preserves endothelial function of the radial artery: comparison with papaverine solution. J Thorac Cardiovasc Surg 1998;115:1321-1327.
97. [97] Cable DG, Caccitolo JA, Pearson PJ, O'Brien T, Mullany CJ, Daly RC, Orszulak TA, Schaff HV. New approaches to prevention and treatment of radial artery graft vasospasm. Circulation 1998;98:II-15-11-22.
98. [98] Bergsma TM, Grandjean JG, Voors AA, Boonstra PW, den Heyer P, Ebels T. Low recurrence of angina pectoris after coronary artery bypass graft surgery with bilateral internal thoracic and right gastroepiploic arteries. Circulation 1998;97:2402-2405.
99. [99] Lafont A, Libby P. The smooth muscle cell: sinner or saint in restenosis and the acute coronary syndromes?. J Am Coll Cardiol 1998;32:283-285.
100. [100] Tardif JC, Côte G, Lesperance J, Bourassa M, Lambert J, Doucet S, Bilodeau L, Nattel S, de Guise P. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group. N Engl J Med 1997;337:365-372.
101. [101] Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. The EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 1998;352:87-92.
102. [102] Moliterno DL, Elliott JM. Randomized trials of myocardial revascularization. Curr Probl Cardiol 1995;20:125-190.
103. [103] Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigators. N Engl J Med 1996;335:217-225.
104. [104] Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997;96:1761-1769.
105. [105] Rozenman Y, Sapoznikov D, Mosseri M, Gilon D, Lotan C, Nassar H, Weiss AT, Hasin Y, Gotsman MS. Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation. J Am Coll Cardiol 1997;30:1420-1425.
106. [106] Gum PA, O'Keefe JH Jr, Borkon AM, Spertus JA, Bateman TM, McGraw JP, Sherwani K, Vacek J, McCallister BD. Bypass surgery versus coronary angioplasty for revascularization of treated diabetic patients. Circulation 1997;96 (Suppl II ):II7-II10.
107. [107] Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. A multicenter randomized trial. The Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. J Am Med Assoc 1997;277:715-721.
108. [108] Pocock SJ, Henderson RA, Rickards AF, Hampton JR, King SB III, Hamm CW, Fuel J, Heub W, Goy JJ, Rodriguz A. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995;346:1184-1189.
109. [109] Hlatky MA, Rogers WJ, Johnstone I, Boothroyd D, Brooks MM, Pitt B, Reeder G, Ryan T, Smith H, Whitlow P, Wiens R, Mark DB, for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N Engl J Med 1997;336:92-99.
110. [110] Narins CR, Holmes DR Jr, Topol EJ. A call for provisional stenting: the balloon is back!. Circulation 1998;97:1298-1305.
111. [111] Goy JJ, Eeckhout E. Intracoronary stenting. Lancet 1998;351:1943-1949.
112. [112] Johnson RG, Sirois C, Thurer RL, Sellke FW, Cohn WE, Kuntz RE, Weintraub RM. Predictors of CABG within one year of successful PTCA: a retrospective, case-control study. Ann Thorac Surg 1997;64:3-8.
113. [113] Boylan MJ, Lytle BW, Loop FD, Taylor PC, Borsh JA, Goormastic M, Cosgrove DM. Surgical treatment of isolated left anterior descending coronary stenosis: comparison of left internal mammary artery and venous autograft at 18 to 20 years of follow-up. J Thorac Cardiovasc Surg 1994;107:657-662.
114. [114] McCarthy PM, Lytle BW, Loop FD. et al. The gold standard for isolated left anterior descending revascularization: Conventional internal thoracic artery bypass. Abstract No. 3809. Circulation 1997;96 (Suppl I ):I681.
115. [115] Loop FD, Lytle BW, Cosgrove DM, Woods EL, Stewart RW, Golding LAR, Goormastic M, Taylor PC. Reoperation for coronary atherosclerosis: changing practice in 2509 consecutive patients. Ann Surg 1990;212:3783-3786.
116. [116] Savage MP, Douglas JS Jr, Fischman DL, Pepine CJ, King SB III, Werner JA, Bailey SR, Overlie PA, Fenton SH, Brinker JA, Leon MB, Goldberg S. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med 1997;337:740-747.
117. [117] Plokker HW, Meester BH, Serruys PW. The Dutch experience in percutaneous transluminal coronary angioplasty of narrowed saphenous veins used for aortocoronary arterial bypass. Am J Cardiol 1991;67:361-366.
118. [118] Cosgrove DM, Loop FD, Lytle BW, Gill CC, Golding LA, Gibson C, Stewart RW, Taylor PC, Goormastic M. Predictors of reoperation after myocardial revascularization. J Thorac Cardiovasc Surg 1986;92:811-821.
119. [119] Brener SJ, Loop FD, Lytle BW, Ellis SG, Cosgrove DM, Topol EJ. A profile of candidates for repeat myocardial revascularization: implications for selection of treatment. J Thorac Cardiovasc Surg 1997;114:153-161.
120. [120] Klein LW, Weintraub WS, Agarwal JB, Schneider RM, Seelaus PA, Katz RI, Helfant RH. Prognostic significance of severe narrowing of the proximal portion of the left anterior descending coronary artery. J Am Coll Cardiol 1986;58:42-46.
121. [121] Lytle BW, Loop FD, Taylor PC, Goormastic M, Stewart RW, Novoa R, McCarthy P, Cosgrove DM. The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg 1993;105:605-614.
122. [122] Mehta ID, Weinberg J, Jones MF, Tellides G, Kopf GS, Shaw RK, Zaret BL, Elefteriades JA. Should angiographically disease-free saphenous vein grafts be replaced at the time of redo coronary artery bypass grafting?. Ann Thorac Surg 1998;65:17-23.
123. [123] Keon WJ, Heggtveit HA, Leduc J. Perioperative myocardial infarction caused by atheroembolism. J Thorac Cardiovasc Surg 1982; 84:849-855.
124. [124] Loop FD. Catastrophic hemorrhage during sternal reentry (editorial). Ann Thorac Surg 1984;37:271-272.
125. [125] Loop FD, Cosgrove DM. Repeat coronary bypass surgery: selection of cases, surgical risks and long-term outlook. Mod Concepts Cardiovasc Dis 1986;55:31-36.
126. [126] Loop FD, Higgins TL, Panda R, Pearce G, Estafanous FG. Myocardial protection during cardiac operations: Decreased morbidity and lower cost with blood cardioplegia and coronary sinus perfusion. J Thorac Cardiovasc Surg 1992;104:608-618.
127. [127] Lytle BW, McElroy D, McCarthy P, Loop FD, Taylor PC, Goormastic M, Stewart RW, Cosgrove DM. Influence of arterial coronary bypass grafts on the mortality in coronary reoperations. J Thorac Cardiovasc Surg 1994;107:675-683.
128. [128] Lytle BW, Navia JL, Taylor PC, Loop FD, Potts WJ, Suszkowski G, Stewart RW, McCarthy PM, Cosgrove DM. III Third coronary artery bypass operations: risks and costs. Ann Thorac Surg 1997;64:1287-1295.
129. [129] Murphy ML, Hulltgren HN, Detre K, Thomsen J, Takaro T. Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration Cooperative Study. N Engl J Med 1977;297:621-627.
130. [130] Wismer J-M. Vista and robotics: new technologies, new frontiers. Perfusion 1998;13:273-277.
131. [131] Shennib J, Batawisy A, Mack MJ, Moll FH. Computer-assisted telemanipulation: an enabling technology for endoscopic coronary artery bypass. Ann Thorac Surg 1998;66:1060-1063.
132. [132] Favaloro RG. Critical analysis of coronary artery bypass graft surgery. A 30-year journey. J Am Coll Cardiol 1988;31:1B-63B.